Startups · AI

AI Biologist - Oligonucleotide Drug Discovery

Latch Bio · San Francisco or Remote · Remote

← All jobs
About Latch Bio

Harmonize your Wet and Dry Lab. Backed by Lux.

About the role

You will contribute to our technical approach to teaching agents how to understand and handle complex drug discovery and development data, working across end-to-end workflows from instrument outputs and experimental readouts to real scientific decisions. You will work as part of a team of software engineers, biologists, and drug hunters building datasets to teach these agents to reason better across:

What they're looking for

  • 3+ years hands-on experience with oligonucleotide (ASO/siRNA), RNA therapeutics, or related
  • Experience in drug target validation or mechanism-of-action studies using functional or population genomics
  • Familiarity with drug discovery and development workflows - sequence design, knockdown screening, or preclinical PK/PD
  • Proficiency in AI agent use
More about this role

As molecular data generation and frontier model intelligence grows, new approaches to data analysis are needed across the biotech industry. Latch is building intelligent, high-performance agents for biological data analysis, empowering over 5,000 scientists across 150+ R&D labs to handle data from instrument-to-insights.

We're seeking a Bioinformatics Engineer to join our Oligonucleotide Drug Discovery working at the frontier of what artificial intelligence can achieve in biology.

You will contribute to our technical approach to teaching agents how to understand and handle complex drug discovery and development data, working across end-to-end workflows from instrument outputs and experimental readouts to real scientific decisions. You will work as part of a team of software engineers, biologists, and drug hunters building datasets to teach these agents to reason better across:

Genetic target and MoA selection

ASO/siRNA drug design

Screening and functional characterization

Pharmacology

3+ years hands-on experience with oligonucleotide (ASO/siRNA), RNA therapeutics, or related

Experience in drug target validation or mechanism-of-action studies using functional or population...

Read the full posting on Latch Bio's site ↗

Research

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.